Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Myelodysplastic Syndromes 1 Cytopenia 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 27 Fluorouracil 23 Leucovorin 22 Cetuximab 22 Bevacizumab 21 Nivolumab 16 Capecitabine 16 Irinotecan 15 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Specimen Handling 10 encorafenib 8 Folfox protocol 7 trifluridine tipiracil drug combination 6 Ipilimumab 6 Exercise 6 fludarabine 5 cemiplimab 5 Trastuzumab 5 Gemcitabine 5 Cyclophosphamide 5 Cisplatin 5 Blood Specimen Collection 5 Biopsy 5 regorafenib 4 pertuzumab 4 adagrasib 4 Trifluridine 4 Pemetrexed 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × HuMax-IL8 × 1 year × Clear all

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡